Fluvastatin XL therapy may prevent adverse cardiac outcomes in patients undergoing major vascular surgery: Results from the DECREASE III trial
Jump to navigation
Jump to search
Redirect to:
News:Fluvastatin XL therapy may prevent adverse cardiac outcomes in patients undergoing major vascular surgery: Results from the DECREASE III trial
Cookies help us deliver our services. By using our services, you agree to our use of cookies.
OK
Navigation menu
Personal tools
Log in
Request account
Namespaces
Home
Page
Discussion
English
Views
Read
View source
View history
Help
More
Search
Tools
What links here
Related changes
Printable version
Permanent link
Page information